The Reply - 24/10/24

Doi : 10.1016/j.amjmed.2024.07.019

Beatriz Castillo Rodriguez, MD ^a, Eric A. Secemsky, MD ^b,^c,^d, Rajesh V. Swaminathan, MD ^e,^f, Dmitriy N. Feldman, MD ^g, Markus Schlaich, MD ^h,^i,^j, Yuri Battaglia, MD, PhD ^k,^l, Edward J. Filippone, MD ^m, Chayakrit Krittanawong, MD ^n,^⁎
^a Division of Internal Medicine, Baylor College of Medicine, Houston, Tex
^b Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass
^c Harvard Medical School, Department of Medicine, Boston, Mass
^d Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass
^e Duke University Medical Center, Department of Medicine, Durham, NC
^f Duke Clinical Research Institute, Department of Medicine, Durham, NC
^g Division of Cardiology, Interventional Cardiology and Endovascular Laboratory, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY
^h Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia
ⁱ Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Western Australia, Australia
^j Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
^k Nephrology and Dialysis Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy
^l Department of Medicine, University of Verona, Verona, Verona, Italy
^m Division of Nephrology, Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
ⁿ Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY

^⁎Requests for reprints should be addressed to Chayakrit Krittanawong, MD, Cardiology Division, NYU Langone Health and NYU School of Medicine, 550 First Avenue, New York, NY 10016Cardiology DivisionNYU Langone Health and NYU School of Medicine550 First AvenueNew YorkNY10016

Le texte complet de cet article est disponible en PDF.

	Funding: None.
	Conflict of Interest: None.
	Authorship: All authors have participated in the preparation of the manuscript. BCR: Writing—review and editing; EAS: Writing—review and editing; RVS: Writing—review and editing; DNF: Writing—review and editing; MS: Writing—review and editing; YB: Writing—review and editing; EJF: Writing—review and editing; CK: Supervision, Writing—original draft, Writing—review and editing.